Ultrasound-guided marker placement and blue dye staining for sentinel lymph node biopsy in early-stage breast cancer

PURPOSE: Ultrasound (US)-guided marker placement is an emerging method for sentinel lymph node biopsy (SLNB), and this study aimed to investigate the concordance between US-guided marker placement for peri-foraminal lymph nodes (LNs) in the axillary cribriform fascia and blue dye-stained SLNs, especially the utility of the two concurrent labeling methods for SLNB in patients with early-stage breast cancer. METHODS: Female patients with clinically staged T1-2N0M0 breast cancer were enrolled. Patients received US-guided marker placement on the day before surgery, followed by blue dye staining. SLN biopsy was performed on the blue dye-stained LNs first and then on the US-guided markers. RESULTS: A total of 96 eligible patients were enrolled. The detection rates of US-guided localization, blue dye, and their combination were 100.0%, 95.8%, and 100.0%, respectively. Among the 92 patients with blue dye staining, US-guided markers were found in blue-stained LNs from 91 patients (concordant) but failed in 1 patient (non-concordant); among the 4 patients without blue-stained LNs. US-guided markers were found in all 4 patients (non-concordant), resulting in a general concordance rate of 94.8% (91/96). Notably, among the 92 patients with blue dye staining, 23 had LN metastasis diagnosed through SLNB, whereas among the 4 patients without blue-stained LNs, the SLNB was performed based on US-guided markers, which revealed 3 patients with LN metastasis and 1 without. Moreover, combining the two labeling methods concurrently identified 26 patients with LN metastasis. CONCLUSION: US-guided localization combined with blue dye concurrently may be a satisfied option for SLNB detection. CLINICAL SIGNIFICANCE: US-guided localization combined with blue dye offers an accessible, anatomically grounded, and radiation-free strategy for optimizing the SLNB procedure, especially in settings where radioactive isotopes are not available.

Authors

Institutions

Publication Details

Journal
Diagnostic and Interventional Radiology
Published
2026-11-12
DOI
https://doi.org/10.4274/dir.2026.263947
Primary Topic
Breast Lesions and Carcinomas
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Ultrasound-guided marker placement and blue dye staining for sentinel lymph node biopsy in early-stage breast cancer

Liang Yongping, Runxue Jiang, Ye Liu, Haifeng Cai et al.
Diagnostic and Interventional Radiology
Breast Lesions and Carcinomas
article

Ultrasound-guided marker placement and blue dye staining for sentinel lymph node biopsy in early-stage breast cancer

Liang Yongping, Runxue Jiang, Ye Liu, Haifeng Cai, Hao Dai, Hongpo Ren, Yang Wang, Yixiao Liao, Xiaoyue Sun, Jianglun Shen, Juan Zhang, Deshun Yao, Yang Zhang, Yimiao Wang, Ming Xin
article en

Abstract

PURPOSE: Ultrasound (US)-guided marker placement is an emerging method for sentinel lymph node biopsy (SLNB), and this study aimed to investigate the concordance between US-guided marker placement for peri-foraminal lymph nodes (LNs) in the axillary cribriform fascia and blue dye-stained SLNs, especially the utility of the two concurrent labeling methods for SLNB in patients with early-stage breast cancer. METHODS: Female patients with clinically staged T1-2N0M0 breast cancer were enrolled. Patients received US-guided marker placement on the day before surgery, followed by blue dye staining. SLN biopsy was performed on the blue dye-stained LNs first and then on the US-guided markers. RESULTS: A total of 96 eligible patients were enrolled. The detection rates of US-guided localization, blue dye, and their combination were 100.0%, 95.8%, and 100.0%, respectively. Among the 92 patients with blue dye staining, US-guided markers were found in blue-stained LNs from 91 patients (concordant) but failed in 1 patient (non-concordant); among the 4 patients without blue-stained LNs. US-guided markers were found in all 4 patients (non-concordant), resulting in a general concordance rate of 94.8% (91/96). Notably, among the 92 patients with blue dye staining, 23 had LN metastasis diagnosed through SLNB, whereas among the 4 patients without blue-stained LNs, the SLNB was performed based on US-guided markers, which revealed 3 patients with LN metastasis and 1 without. Moreover, combining the two labeling methods concurrently identified 26 patients with LN metastasis. CONCLUSION: US-guided localization combined with blue dye concurrently may be a satisfied option for SLNB detection. CLINICAL SIGNIFICANCE: US-guided localization combined with blue dye offers an accessible, anatomically grounded, and radiation-free strategy for optimizing the SLNB procedure, especially in settings where radioactive isotopes are not available.

Diagnostic and Interventional Radiology
North China University of Science and Technology (CN), Tangshan People's Hospital (CN)
Wu Jieping Medical Foundation
Good health and well-being
Breast Lesions and Carcinomas
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon